A Phase 3 interventional study of condroflex and exercise and sugar pill and exercise in Treatment, Osteoarthritis and Elderly, sponsored by Zodiac Produtos Farmaceuticos S.A.. Status unknown at 1 site in Brazil. Open to participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2009-10-12.
Sponsored by Zodiac Produtos Farmaceuticos S.A. · Phase 3, Interventional, and Treatment
Primary Objective: To compare, after 12 weeks of double-blind treatment, the evolution of the improvement of pain (at rest and during / after exercise) in the questionnaire WOMAC (Western Ontario and McMaster Universities Arthritis Index), achieved with Condroflex ® oral administration(sulfate glucosamine + chondroitin sulfate sodium) in association with therapeutic exercises, compared to placebo in association with therapeutic exercises in individuals with knee OA and not exposed to prior treatment with the products under investigation.
To have osteoarthritis degree 2 or 3 / To be capable to consent
4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.
This study's planned enrollment of 240 is above the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.
Browse Osteoarthritis studies →Zodiac Produtos Farmaceuticos S.A. is the lead sponsor of 6 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
assent arm
Other: condroflex and exercise
sugar pill arm
Other: sugar pill and exercise
1 sachet oral once a day by 12 Weeks / therapeutic exercise 3 times a week
Also known as: glucosamine sulph + chondroitin sulph and therapeutic exerc.
1 sachet oral once a day by 12 Weeks / therapeutic exercise 3 times a week
Also known as: Placebo Comparator and therapeutic exerc.
improvement of pain
Time frame: 12 week
rigidity restriction
Time frame: 12 week
This study is status unknown, as verified in Oct 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zodiac Produtos Farmaceuticos S.A.